Malaysian Genomics Resource Cash Flow Quality Index
Malaysian Genomics Resource cash flow quality index. Malaysian Genomics Resource (0155) has a Cash Flow Quality Index of 1.53x as of June 2026. Operating cash flow of RM1.01 Million exceeds net income of RM660.00K, indicating high earnings quality where cash backs reported profits. Explore Malaysian Genomics Resource debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Malaysian Genomics Resource (2015–2022)
Cash flow quality index of Malaysian Genomics Resource from 2015 to 2022. Historical Cash Flow Quality Index for Malaysian Genomics Resource across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 0155 equity to assets ratio to measure how much of total assets are equity-financed.
Malaysian Genomics Resource Cash Flow Quality Index by Year (2015–2022)
Malaysian Genomics Resource cash flow quality index by year from 2015 to 2022. Year-by-year earnings quality comparison for Malaysian Genomics Resource. For the full cash flow conversion analysis, see Malaysian Genomics Resource (0155) cash flow conversion.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | RM56.92K | RM7.21 Million | ▼ -98.8% |
| 2020 | 0.68x | RM11.67 Million | RM17.10 Million | ▼ -87.6% |
| 2017 | 5.50x | RM3.67 Million | RM668.26K | ▲ +160.8% |
| 2016 | 2.11x | RM3.68 Million | RM1.75 Million | ▲ +1833.3% |
| 2015 | 0.11x | RM395.83K | RM3.63 Million | — |